16 December 2009





("Sareum" or the "Company") 

Result of AGM

The Company announces that at the annual general meeting, held earlier today, all resolutions were duly passed.

Further to the announcement made on 19 October 2009, the Company confirms that its Nominated Adviser is Merchant John East Securities Limited and its broker is Hybridan LLP.



Sareum Holdings plc


Tim Mitchell

01223 497 700

Merchant John East Securities Limited (Nominated Adviser)

Simon Clements/Bidhi Bhoma

020 7628 2200

Hybridan LLP (Broker)


Claire Noyce/Stephen Austin

020 3159 5085


Notes for editors:

About Sareum Holdings plc


Sareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.

Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.

Sareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR.  For further information, please visit www.sareum.co.uk